Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$240,447,381
-$93,761,878 QoQ
Shares Held
1,903,177
-20.6% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#80
of 2,275 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. GILD ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,043,205 | $175,349,471 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,447,381 | 1,903,177 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $334,209,259 | 2,398,000 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $307,493,156 | 2,505,240 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $273,285,885 | 2,462,035 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $266,490,457 | 2,403,630 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $194,158,875 | 2,101,969 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $171,671,538 | 2,047,609 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $127,476,487 | 1,857,987 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $134,489,050 | 1,836,028 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $134,509,813 | 1,660,410 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $125,453,756 | 1,674,056 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $132,888,255 | 1,724,254 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $142,782,741 | 1,720,896 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $155,811,654 | 1,814,929 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $108,908,636 | 1,765,418 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $108,653,388 | 1,757,861 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $107,428,884 | 1,807,046 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $130,999,330 | 1,804,150 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $129,317,495 | 1,851,360 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $136,257,550 | 1,978,762 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $157,495,359 | 2,436,877 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||